What questions should I ask my oncologist about metastatic Multiple Myeloma
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Questions to Ask Your Oncologist About Metastatic Multiple Myeloma
I'll help you prepare for your conversation with your oncologist. According to the NCCN Guidelines for Patients: Multiple Myeloma, here are the most important questions organized by topic:
UNDERSTANDING YOUR DIAGNOSIS & DISEASE STATUS
-
What stage is my myeloma, and what does that mean for my treatment options?
- Understanding your disease burden (how much cancer is present) helps you know what to expect
-
What specific tests showed I have myeloma, and what do my results tell us about my cancer?
- Ask about your M protein levels, free light chains, and any genetic abnormalities found in your bone marrow biopsy
-
Do I have any high-risk genetic features in my myeloma cells? (such as deletions or translocations)
- These findings affect which treatments work best and how aggressive your cancer may be
-
How is my kidney function, and are there any organ complications from the myeloma?
- Myeloma can damage kidneys and bones, so knowing your baseline is important
TREATMENT PLANNING
-
What is my primary treatment plan, and why did you choose this combination?
- According to NCCN Guidelines, typical first-line treatment often includes a combination of three or four drugs (called triplet or quadruplet therapy), which might include a targeted therapy, immunomodulator, monoclonal antibody, and corticosteroid
-
Am I a candidate for a hematopoietic cell transplant (blood stem cell transplant)?
- This is a major treatment decision that affects your overall strategy. Your doctor will evaluate your fitness level, health status, and organ function
-
If I'm eligible for a transplant, when would it happen in my treatment plan?
- Typically, stem cells are collected after 4-6 cycles of initial treatment when myeloma cell numbers are low
-
What are the specific drugs in my treatment plan, and what do they do?
- Ask your doctor to explain each medication and how it targets myeloma cells
SIDE EFFECTS & SUPPORTIVE CARE
-
What are the most common side effects I should expect, and how will we manage them?
- Common side effects include fatigue, nausea, low blood cell counts, and neuropathy (numbness/tingling in hands/feet)
-
Will I need bone-building therapy?
- NCCN Guidelines recommend bisphosphonates or denosumab to protect bones, which is very common in myeloma treatment
-
What supportive care will I receive to manage symptoms?
- This might include radiation for bone pain, blood thinners if needed, or other medications to ease side effects
-
How often will I need blood tests and imaging to monitor my treatment?
- Follow-up tests typically include blood work, imaging (PET/CT, MRI, or CT scans), and urine tests
TREATMENT RESPONSE & WHAT COMES NEXT
-
How will we know if the treatment is working?
- Your doctor will look for decreasing M protein levels, improved blood counts, and imaging showing fewer myeloma cells
-
What does remission mean, and is that a realistic goal for me?
- Remission means signs and symptoms decrease or disappear. While myeloma can't currently be cured, new treatments are helping people live longer with better quality of life
-
What happens after my initial treatment ends?
- Many patients move to maintenance therapy (lower-dose medication to keep results stable) or may need additional treatment if myeloma comes back
-
If my myeloma comes back or becomes resistant to treatment, what options will we have?
- According to NCCN Guidelines, newer options like CAR T-cell therapy and bispecific antibodies are available for relapsed or resistant myeloma
CLINICAL TRIALS & SECOND OPINIONS
-
Are there clinical trials available that might be appropriate for me?
- Clinical trials offer access to newer treatments and may be worth discussing
-
Would it be helpful to get a second opinion from a myeloma specialist?
- NCCN Guidelines recommend considering a cancer specialist or center experienced in treating myeloma, as treatment decisions made early can affect later options
YOUR ROLE IN CARE
-
How can I best support my treatment and stay healthy during therapy?
- Ask about exercise, nutrition, infection prevention, and managing side effects at home
-
What should I do if I experience side effects or have concerns between appointments?
- Know who to contact and when to seek immediate care
KEY TAKEAWAY
According to the NCCN Guidelines for Patients, being your own advocate by asking questions helps you make better decisions about your care. Don't hesitate to ask your team to explain anything you don't understand—cancer care is complex, and your oncologist expects these questions.
Consider bringing a trusted family member or friend to appointments to help you remember information and take notes. You might also ask if your oncologist can provide written summaries of your test results and treatment plan.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Multiple Myeloma (2026)Browse all NCCN Guidelines for Patients →Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
What is the life expectancy for multiple myeloma cancer
I understand this is one of the most important questions you might have. Let me share what the current medical evidence shows, while being clear about
What is the 5-year survival rate for multiple myeloma
I appreciate this important question, but I need to be transparent with you: the NCCN Guidelines for Patients materials I have access to don't include
What is the average survival rate for multiple myeloma by stage
I appreciate this important question. However, I need to be direct with you: the NCCN Guidelines for Patients that I have access to do not include spe